Showing results (781-790 of 824) with videos related to

Sort By:
Pageof 83
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 23, 2013
Impact of time-to-treatment on myocardial perfusion after primary percutaneous coronary intervention with Gp IIb-IIIa inhibitorsGiuseppe De Luca, Michael C Gibson, Arnoud W J Van't Hof, et al.
The American Journal of Cardiology|August 6, 2013
Impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with ST segment elevation myocardial infarction undergoing primary angioplastyGiuseppe De Luca, Arnoud W J van't Hof, Kurt Huber, et al.
Epidemics|November 17, 2024
Forecasting SARS-CoV-2 epidemic dynamic in Poland with the pDyn agent-based modelKarol Niedzielewski, Rafał P Bartczuk, Natalia Bielczyk, et al.
Journal of Thrombosis and Thrombolysis|November 26, 2008
Benefits of pharmacological facilitation with glycoprotein IIb-IIIa inhibitors in diabetic patients undergoing primary angioplasty for STEMI. A subanalysis of the EGYPT cooperationGiuseppe De Luca, C Michael Gibson, Francesco Bellandi, et al.
Angewandte Chemie (International Ed. in English)|June 18, 2025
Automated Iterative N─C and C─C Bond FormationTheodore Tyrikos-Ergas, Sevasti Agiakloglou, Antonio J LaPorte, et al.
Journal of Thrombosis and Thrombolysis|March 10, 2010
Gender-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperationGiuseppe De Luca, C Michael Gibson, Mariann Gyöngyösi, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 1, 1996
Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by EchocardiographyH Rakowski, C Appleton, K L Chan, et al.
Heart Rhythm|December 21, 2021
Importance of newer cardiac magnetic resonance-based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter studyEthan J Rowin, Martin S Maron, Arnon Adler, et al.
The Canadian Journal of Cardiology|June 24, 2023
Clinical Significance of Postoperative Atrial Fibrillation in Hypertrophic Cardiomyopathy Patients Undergoing Septal MyectomyRoxana Bataiosu, Sara Hoss, Fernando L Scolari, et al.
Archives of Cardiovascular Diseases|April 16, 2013
Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitorsGiuseppe De Luca, Michael Gibson, Donald Cutlip, et al.
Pageof 83